🇺🇸 FDA
Pipeline program

A bioavailability study of epinephrine following a single dose of emergency response auto-injector in comparison to epinephrine injection into muscle via syringe in healthy adults.

EPIN-IJS-1002

Phase 1 other active

Quick answer

A bioavailability study of epinephrine following a single dose of emergency response auto-injector in comparison to epinephrine injection into muscle via syringe in healthy adults. for Allergic reactions (Type 1), including anaphylaxis, idiopathic anaphylaxis or exercise-induced anaphylaxis is a Phase 1 program (other) at Mylan dura GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Mylan dura GmbH
Indication
Allergic reactions (Type 1), including anaphylaxis, idiopathic anaphylaxis or exercise-induced anaphylaxis
Phase
Phase 1
Modality
other
Status
active

Clinical trials